Literature DB >> 16407515

Optimizing ACE-inhibitor therapy for chronic kidney disease.

Lee A Hebert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16407515     DOI： 10.1056/NEJMe058295

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Is fluid overload as measured by bioimpedance spectroscopy harmful in CKD-if so, why?

Authors:  Lee A Hebert; Samir Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-15       Impact factor: 8.237

2.  Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.

Authors:  Eric S Johnson; Jessica R Weinstein; Micah L Thorp; Robert W Platt; Amanda F Petrik; Xiuhai Yang; Sharon Anderson; David H Smith
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-03       Impact factor: 2.890

3.  Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.

Authors:  Ali Ahmed; Gregg C Fonarow; Yan Zhang; Paul W Sanders; Richard M Allman; Donna K Arnett; Margaret A Feller; Thomas E Love; Inmaculada B Aban; Raynald Levesque; O James Ekundayo; Louis J Dell'Italia; George L Bakris; Michael W Rich
Journal:  Am J Med       Date:  2012-02-07       Impact factor: 4.965

4.  Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.

Authors:  Ali Ahmed; Michael W Rich; Michael Zile; Paul W Sanders; Kanan Patel; Yan Zhang; Inmaculada B Aban; Thomas E Love; Gregg C Fonarow; Wilbert S Aronow; Richard M Allman
Journal:  Am J Med       Date:  2013-02       Impact factor: 4.965

Review 5.  Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease.

Authors:  Chakradhari Inampudi; Paulino Alvarez; Rabea Asleh; Alexandros Briasoulis
Journal:  Curr Cardiol Rev       Date:  2018-03-14

Review 6.  Renal dysfunction in heart failure patients: what is the evidence?

Authors:  Heath E Saltzman; Kumar Sharma; Paul J Mather; Sharon Rubin; Suzanne Adams; David Joshua Whellan
Journal:  Heart Fail Rev       Date:  2007-03-29       Impact factor: 4.654
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.